Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthcare Services (HCSG) EBITDA (2016 - 2025)

Historic EBITDA for Healthcare Services (HCSG) over the last 17 years, with Q4 2025 value amounting to $31.5 million.

  • Healthcare Services' EBITDA rose 21129.65% to $31.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $103.0 million, marking a year-over-year increase of 5227.72%. This contributed to the annual value of $60.9 million for FY2025, which is 5623.37% up from last year.
  • Latest data reveals that Healthcare Services reported EBITDA of $31.5 million as of Q4 2025, which was up 21129.65% from $43.7 million recorded in Q3 2025.
  • Healthcare Services' EBITDA's 5-year high stood at $43.7 million during Q3 2025, with a 5-year trough of -$6.7 million in Q3 2023.
  • For the 5-year period, Healthcare Services' EBITDA averaged around $13.8 million, with its median value being $11.6 million (2021).
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 23962.46% in 2023, then surged by 34085.75% in 2024.
  • Healthcare Services' EBITDA (Quarter) stood at $4.8 million in 2021, then soared by 270.57% to $17.8 million in 2022, then surged by 48.53% to $26.4 million in 2023, then crashed by 61.7% to $10.1 million in 2024, then soared by 211.3% to $31.5 million in 2025.
  • Its EBITDA was $31.5 million in Q4 2025, compared to $43.7 million in Q3 2025 and $17.7 million in Q1 2025.